Nazila Habibizad SEC EDGAR Filings (CIK 0001913961)

SEC EDGAR filings, ownership reports, and insider transactions for Nazila Habibizad.

Business address
C/O Global Blood Therapeutics, Inc., 181 Oyster Point Blvd, South San Francisco, CA, 94080
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Nazila Habibizad has filed 10 SEC EDGAR filings since 03 Mar 2022

Latest Filings

Recent SEC filings for Nazila Habibizad including 4, 3/A, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Oct 2022 05 Oct 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 04 Oct 2022 01 Oct 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 29 Sep 2022 27 Sep 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 06 Sep 2022 01 Sep 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Aug 2022 18 Aug 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Aug 2022 01 Aug 2022 001-37539
3/A Open 3/A document View SEC filing for 3/A FORM 3/A SUBMISSION 03 Aug 2022 01 Mar 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 05 Apr 2022 01 Apr 2022 001-37539
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 03 Mar 2022 01 Mar 2022 001-37539
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 03 Mar 2022 01 Mar 2022 001-37539

About this filer

Nazila Habibizad files with the SEC under CIK 0001913961. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages